Not Yet RecruitingPhase 4

Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy

Thailand94 participantsStarted 2024-05-01

Plain-language summary

The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are: Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment? Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy. Participants will: * Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks * Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with insertional Achilles tendinopathy * Had symptom more than 6 months * Failed other standard conservative treatment (rest, medication, activity modification, stretching exercise, and heel lift orthosis) Exclusion Criteria: * Receive corticosteroid injection at the Achilles insertion * History of infection around ankle and heel * Has neurological deficit * Has a contraindication for ESWT(hemophilia, coagulopathy or foot and ankle malignancy)

What they're measuring

VAS

Timeframe: 6 week, 3 months, 6 months and 1 year after treatment

Trial details

NCT IDNCT06384859

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-01